<DOC>
	<DOCNO>NCT00102063</DOCNO>
	<brief_summary>The purpose trial test safety efficacy aripiprazole adolescent patient schizophrenia period least 6 week .</brief_summary>
	<brief_title>Aripiprazole Adolescents With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Primary diagnosis Schizophrenia 1 Patients diagnosed schizoaffective disorder , major depressive disorder , delirium , bipolar disorder</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Aripiprazole</keyword>
</DOC>